Janus kinase inhibitor for anti-transcription intermediary factor 1-γ positive cancer-associated dermatomyositis-Reference-Cited by-同舟云学术

Janus kinase inhibitor for anti-transcription intermediary factor 1-γ positive cancer-associated dermatomyositis

Published:2023-10-18 Issue:2 Volume:190 Page:285-287
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Wu Wanlong¹²^ORCID,Chen Jinju¹,Zhu Linling¹,Sha Yaping¹,Wang Kaiwen¹^ORCID,Zhao Jiangfeng¹²,Ye Chunhua¹,Ye Shuang¹^ORCID

Affiliation:

1. Department of Rheumatology

2. Jiading Branch, Renji Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China

Abstract

In this retrospective case series, off-label use of Janus kinase inhibitor rapidly and significantly ameliorated the active cutaneous disease in all five glucocorticoid-resistant patients with cancer-associated dermatomyositis who had anti-transcription intermediary factor 1-γ antibodies, showing a promising steroid-sparing effect and a generally well-tolerated safety profile beyond 1-year follow-up.

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://academic.oup.com/bjd/advance-article-pdf/doi/10.1093/bjd/ljad396/54022805/ljad396.pdf

Reference8 articles.

1. Risk-based screening for cancer in patients with dermatomyositis: toward a more individualized approach;Vaughan;JAMA Dermatol,2022

2. Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis;Okiyama;Ann Rheum Dis,2021

3. Study of tofacitinib in refractory dermatomyositis: an open-label pilot study of ten patients;Paik;Arthritis Rheumatol,2021

4. 239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018;Mammen;Neuromuscul Disord,2020

5. Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index (CASDI): characterizing disease severity and assessing responsiveness to clinical change;Anyanwu;Br J Dermatol,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons;Expert Opinion on Pharmacotherapy;2024-08-12